The Vaccine-Autism ConnectionAlthough a vaccine/autism connection has been dismissed repeatedly in the current media, scientific studies that are based on biological processes show a significant link. CDC epidemiological studies also show a strong link of thimerosal to ADD, Learning Disabilities, Speech Delay and Autism (see Geier footage). These studies may not have received high attention in the public as of yet, but the information explaining what health professionals and government and otherwise employed scientists have discovered is in this section.
To access the video clips, click the links beneath the Quicktime or Windows Media format icons for either the "Low" bandwidth (dial-up connection) or "High" bandwidth (DSL or Broadband) sizes.All video clips are the copyright of the Foundation for Autism Information and Research (F.A.I.R. Autism Media) and are intended for informational purposes only. The content herein is not intended as medical advice.
You will need Windows Media Player, or Quicktime Player to view these clips.
––––––––––––––––––––––––––––––––––––––––––––––––––––
Dr. Cave received her M.S. in Clinical Chemistry in 1978 and M.D. from Louisiana State University Medical School in New Orleans in 1983. She completed a residency in 1986 and is board certified in Family Practice. On the clinical faculty of LSU Medical School, she is in the private practice of medicine in Baton Rouge, Louisiana. She has treated over 3000 children in the autism spectrum. Dr. Cave lectures throughout the country on autism, heavy metal toxicity, and vaccines, and has authored a book titled, What Your Doctor May Not Tell You About Children's Vaccinations. She has appeared on CNN in a special about autism and vaccines, and testified before a Louisiana State Legislative Committee and the United States Congressional Committee on Governmental Reform regarding mercury in vaccines in July, 2000.
This interview was filmed in February, 2007 and is currently only available in Quicktime format.
Dr. Burbacher is Associate Professor in the Department of Environmental and Occupational Health in the School of Public Health and Community Medicine at the University of Washington. He has been involved in research in the area of mercury developmental neurotoxicity for several decades and was a member of the 2000 National Academy of Sciences panel on methylmercury.
In this interview, Dr. Burbacher describes the results of a recent study on the blood and brain levels of different mercury species in infant nonhuman primates following oral methylmercury exposure or exposure to vaccines containing thimerosal. The results of the study indicate several differences in the distribution and clearance of mercury from these two sources. These differences point out the importance of providing specific data on mercury derived from thimerosal for an evaluation of the safety of early exposure to mercury from vaccines containing thimerosal.
Mady Hornig, MD, Associate Professor of Epidemiology at Columbia University, is Director of Translational Research in the Center for Immunopathogenesis and Infectious Diseases at the Mailman School of Public Health. A physician-scientist, she is widely recognized for her work on the role of viral and immune factors in neurodevelopmental and other neuropsychiatric disorders, and the neuropharmacologic and neuroendocrine aspects of treatment resistant mood disorders, obsessive-compulsive disorder, and attention deficit/hyperactivity disorder in adults.
Dr. Hornig’s translational research focuses on understanding the mechanisms by which infection, immune disturbances, and neurotoxins lead to neurodevelopmental damage or CNS dysfunction, contributing to neuropsychiatric conditions such as autism, schizophrenia, attention deficit/hyperactivity disorder, obsessive compulsive disorders, and mood disorders. Her research program integrates data from animal models and epidemiologic studies, incorporating behavioral, neurochemical, neurostructural, molecular, immunologic and microbiologic perspectives. She serves as Director of Clinical Core for a large, international multicenter program, led by Dr. Ian Lipkin, that is evaluating the role of Borna disease virus in human neuropsychiatric diseases, and as co-PI for a study of measles virus sequences in bowel biopsies of children with autism.
Dr. Haley received his BS in Chemistry/Physics from Franklin College in 1963. After a tour in the U.S. Army he completed his M.S. in Chemistry at the University of Idaho (1966) and his Ph.D. in Chemistry/Biochemistry at Washington State University (1971). He was an NIH Postdoctoral Scholar in the Department of Physiology, Yale University Medical School from 1971 to 1974. His first academic appointment was at the University of Wyoming in 1974 where he was promoted to full professor in 1983. In 1985 he was appointed as the first scientist hired in the Markey Cancer Center at the University of Kentucky with academic appointments as professor in the College of Pharmacy and in the Department of Biochemistry of the University of Kentucky Medical Center. In 1996 he was named Professor and Chair of the Department of Chemistry.
Dr. Haley has testified as an expert witness at government hearings on the issue of the health hazards of mercury in vaccines and dental amalgam.
Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the Genetic Centers of America, which for the past 23 years has offered clinical prenatal genetics services to the Northern Virginia, Washington, D.C., and Baltimore areas. Dr. Geier has worked in the fields of molecular and cell biology and genetic engineering at the National Institutes of Health for ten years. Dr. Geier has also been a professor at The Johns Hopkins University Hospital.
Visit Dr. Wakefield's website for more information.
Dr. Wakefield discusses his research and the biological difficulties associated with the MMR vaccine as it relates to Autism. Dr. Andrew Wakefield is an academic gastroenterologist. He graduated in Medicine from St. Mary’s Hospital, part of the University of London, in 1981, and pursued a career in gastrointestinal surgery with a specific interest in inflammatory bowel disease. He qualified as Fellow of the Royal College of Surgeons in 1985, and in 1996 he was awarded a Wellcome Trust Traveling Fellowship to study small intestinal transplantation in Toronto, Canada.
The main focus of Dr. Wakefield’s research is an investigation of the immunologic, metabolic, and pathologic changes occurring in inflammatory bowel diseases such as autistic enterocolitis, links between intestinal disease and neurologic injury in children, and the potential relationship of these conditions to environmental causes, such as childhood vaccines.----------
Jon Pangborn, Ph.D., received a doctoral degree in chemical engineering. After working in nuclear research and the field of alternative fuels, he became interested in the biochemistry of human metabolism. He developed a novel procedure for evaluating amino acid analyses and founded Bionostics, Inc., as a consulting organization. He is a holder of 9 U. S. patents, and author of over 200 publications and presentations. Dr. Pangborn is Fellow of the American Institute of Chemists, is certified as a Clinical Nutritionist, and serves regularly on the faculties of the American Academy of Environmental Medicine and the American Academy of Otolaryngic Allergy. He works closely with Dr. Bernard Rimland in the area of autism research, and also maintains a database on Tourette syndrome.
----------
Dr. Richard Deth, Professor of Pharmacology, Department of Pharmaceutical Science, Northeastern University, discusses research on the biochemical pathway of mercury exposure and explains, from the cellular level, the effect that mercury has on the developing nervous system.
----------
Visit Dr. Shaw's website for more information.
William Shaw, Ph.D. obtained his doctorate in biochemistry, genetics, and human physiology from the Medical University of South Carolina. He is certified in the fields of clinical chemistry and toxicology by the American Board of Clinical Chemistry.
Dr. Shaw worked for six years in nutritional biochemistry, endocrinology and immunology at the US Centers for Disease Control and for twelve years in Smith Kline Beecham Clinical Laboratories where he was involved with specialized medical testing for toxicology (poisons and drugs), immunology, tumor receptors and endocrinology. For the subsequent five years, William was an associate professor at the University of Missouri at Kansas City (UMKC) School of Medicine. At the same time, he served as Director of Clinical Chemistry, Toxicology and Endocrinology and the organic acid testing for metabolic conditions at UMKC's Children’s Mercy Hospital.
Currently, William serves as Director of The Great Plains Laboratory for health, metabolism and nutrition in Lenexa, Kansas. He specializes in metabolic and nutritional factors in a wide range of human diseases, with a special focus on the the metabolic, infectious, nutritional, and immunological causes of autism and PDD.
----------
Visit Dr. Usman's website for more information.
